Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
- 28 May 2018
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 117 (8) , 1687-1696
Abstract
Background: The optimal treatment strategy for patients with esophageal adenocarcinoma (EAC) remains undetermined. This study compared outcomes in patients undergoing neoadjuvant chemotherapy (nCT) and neoadjuvant chemoradiotherapy (nCRT) for EAC.Methods: Patients who underwent nCT or nCRT followed by surgery for EAC were identified from a prospective database (2000‐2017) and included. After propensity score matching, the impact of the treatments on postoperative complications, in‐hospital mortality, pathological outcomes, and survival rates were compared.Results: Of the 396 eligible patients, 262 patients were analysed following matching with 131 patients in both groups. There were no significant differences between the nCT and nCRT groups for overall complications (59% vs 57%, P = 0.802) or in‐hospital mortality (2% vs 0%, P = 0.156). Patients who had nCRT had more R0 resections (93% vs 83%, P = 0.013), and higher pathological complete response rates (15% vs 5%, P < 0.001). No differences in 5‐year overall survival rates (nCT vs nCRT; 44% vs 33%, P = 0.645) were found.Conclusion: In this study no differences between nCT and nCRT were seen in postoperative complications and in‐hospital mortality in patients treated for EAC. Inspite of improved complete resection and pathological response there was no difference in the overall survival between the treatment modalities.Keywords
Funding Information
- Swedish Medical Council
This publication has 27 references indexed in Scilit:
- Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialEuropean Journal of Cancer, 2011
- Pathologic Response after Neoadjuvant Therapy is the Major Determinant of Survival in Patients with Esophageal CancerAnnals of Surgical Oncology, 2010
- Phase III Comparison of Preoperative Chemotherapy Compared With Chemoradiotherapy in Patients With Locally Advanced Adenocarcinoma of the Esophagogastric JunctionJournal of Clinical Oncology, 2009
- Complete Pathologic Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer Is Associated With Enhanced SurvivalThe Annals of Thoracic Surgery, 2009
- Comparison of the Outcomes Between Open and Minimally Invasive EsophagectomyAnnals of Surgery, 2007
- Surgical Complications Do Not Affect Longterm Survival after Esophagectomy for Carcinoma of the Thoracic Esophagus and CardiaJournal of the American College of Surgeons, 2006
- The Influence of Technical Complications on Postoperative Outcome and Survival After EsophagectomyAnnals of Surgical Oncology, 2006
- The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinomaJournal of the American College of Surgeons, 2004
- Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trialThe Lancet, 2002
- The central role of the propensity score in observational studies for causal effectsBiometrika, 1983